C
Catherine Stanton
Researcher at Teagasc
Publications - 592
Citations - 52749
Catherine Stanton is an academic researcher from Teagasc. The author has contributed to research in topics: Gut flora & Microbiome. The author has an hindex of 98, co-authored 540 publications receiving 40765 citations. Previous affiliations of Catherine Stanton include National University of Ireland & University College Cork.
Papers
More filters
Journal ArticleDOI
Dietary vitamin A supplementation prevents early obesogenic diet-induced microbiota, neuronal and cognitive alterations.
Essi F. Biyong,Serge Alfos,Fabien Dumetz,Jean-Christophe Helbling,Agnès Aubert,Julie Brossaud,Aline Foury,Marie-Pierre Moisan,Sophie Layé,Emmanuel Richard,Elaine Patterson,Kiera Murphy,Kieran Rea,Catherine Stanton,Harriët Schellekens,John F. Cryan,Lucile Capuron,Véronique Pallet,Guillaume Ferreira +18 more
TL;DR: Dietary VAS was protective against the deleterious effects of early obesogenic diet consumption on hippocampal function, possibly through modulation of the gut–brain axis.
Journal ArticleDOI
Protective effect of Bifidobacterium bifidum FSDJN7O5 and Bifidobacterium breve FHNFQ23M3 on diarrhea caused by enterotoxigenic Escherichia coli
Bo Yang,Zheng Huang,Zhujun He,Yue Yue,Yonghua Zhou,R. Paul Ross,R. Paul Ross,Catherine Stanton,Catherine Stanton,Catherine Stanton,Hao Zhang,Jianxin Zhao,Wei Chen +12 more
TL;DR: In this article, a mouse model was used to evaluate the effect of Bifidobacterium on alleviating diarrhea caused by ETEC, and the results showed that B. breve FHNFQ23M3 and B. bifidum FSDJN7O5 could relieve the symptoms of diarrhea, which significantly reduced the stool water content, restored the villi structure in the jejunum and ameliorated the fecal short chain fatty acid (SCFA) content.
Journal ArticleDOI
Exploring the Gut Microbiota and Cardiovascular Disease
Kiera Murphy,Kiera Murphy,Aoife N O'Donovan,Aoife N O'Donovan,Noel M. Caplice,R. Paul Ross,Catherine Stanton,Catherine Stanton +7 more
TL;DR: In this article, the authors summarized the current knowledge on the role of the gut microbiome in CVD development, and associated microbial communities, functions, and metabolic profiles, and discussed CVD therapeutic interventions that target the gut microbiota such as probiotics and faecal microbiota transplantation.